VRTX
Vertex Pharmaceuticals Inc
Price:  
468.00 
USD
Volume:  
1,090,351.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex WACC - Weighted Average Cost of Capital

The WACC of Vertex Pharmaceuticals Inc (VRTX) is 8.7%.

The Cost of Equity of Vertex Pharmaceuticals Inc (VRTX) is 8.70%.
The Cost of Debt of Vertex Pharmaceuticals Inc (VRTX) is 6.95%.

Range Selected
Cost of equity 7.60% - 9.80% 8.70%
Tax rate 15.10% - 16.30% 15.70%
Cost of debt 4.50% - 9.40% 6.95%
WACC 7.6% - 9.8% 8.7%
WACC

Vertex WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.82 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 9.80%
Tax rate 15.10% 16.30%
Debt/Equity ratio 0 0
Cost of debt 4.50% 9.40%
After-tax WACC 7.6% 9.8%
Selected WACC 8.7%